IC
IEQ Capital Portfolio holdings
AUM
$16.3B
1-Year Return
39.51%
This Quarter Return
+25.09%
1 Year Return
+39.51%
3 Year Return
+152.4%
5 Year Return
+193.99%
10 Year Return
–
AUM
$16.3B
AUM Growth
+$3.77B
(+30%)
Cap. Flow
+$1.26B
Cap. Flow
% of AUM
7.69%
Top 10 Holdings %
Top 10 Hldgs %
35.29%
Holding
2,029
New
422
Increased
852
Reduced
463
Closed
222
Top Buys
| 1 |
NVIDIA
NVDA
|
+$131M |
| 2 |
Upbound Group
UPBD
|
+$95.4M |
| 3 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$75.2M |
| 4 |
Vanguard Total International Stock ETF
VXUS
|
+$51.3M |
| 5 |
Arista Networks
ANET
|
+$35.5M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$128M |
| 2 |
Apollo Global Management
APO
|
+$70.2M |
| 3 |
Carvana
CVNA
|
+$59.1M |
| 4 |
PDX
PIMCO Dynamic Income Strategy Fund
PDX
|
+$51.3M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$45.8M |
Sector Composition
| 1 | Technology | 24.35% |
| 2 | Communication Services | 20.35% |
| 3 | Financials | 9.77% |
| 4 | Consumer Discretionary | 8% |
| 5 | Healthcare | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
URG
1776
Ur-Energy
URG
$529M
| $36.3K | ﹤0.01% |
+34,578
| New | +$36.3K |
|
1777
CEMIG Preferred Shares
CIG
$5.78B
| $34.7K | ﹤0.01% |
+17,711
| New | +$34.7K |
|
1778
Kyverna Therapeutics
KYTX
$169M
| $34K | ﹤0.01% |
11,068
-1,207
| -10% | -$3.71K |
|
1779
Banco Bradesco
BBD
$33.3B
| $32.9K | ﹤0.01% |
+10,661
| New | +$32.9K |
|
1780
HilleVax
HLVX
$105M
| $32.7K | ﹤0.01% |
16,453
-3,762
| -19% | -$7.49K |
|
|
IGMS
1781
DELISTED
IGM Biosciences
IGMS
| $30.7K | ﹤0.01% |
27,410
-10,012
| -27% | -$11.2K |
|
1782
MaxCyte
MXCT
$150M
| $30.3K | ﹤0.01% |
13,881
+2,804
| +25% | +$6.11K |
|
|
GPMT
1783
Granite Point Mortgage Trust
GPMT
$141M
| $30.1K | ﹤0.01% |
12,187
-22,894
| -65% | -$56.5K |
|
1784
Olaplex Holdings
OLPX
$987M
| $28.6K | ﹤0.01% |
20,402
+10,241
| +101% | +$14.3K |
|
1785
Clover Health Investments
CLOV
$1.4B
| $28.5K | ﹤0.01% |
10,214
| – | – |
|
1786
C4 Therapeutics
CCCC
$193M
| $26.9K | ﹤0.01% |
18,822
+635
| +3% | +$908 |
|
1787
Holley
HLLY
$451M
| $26.7K | ﹤0.01% |
+13,330
| New | +$26.7K |
|
1788
Clean Energy Fuels
CLNE
$539M
| $25.7K | ﹤0.01% |
13,199
-51,577
| -80% | -$101K |
|
|
TPIC
1789
DELISTED
TPI Composites
TPIC
| $24K | ﹤0.01% |
27,887
+2,201
| +9% | +$1.89K |
|
1790
Taysha Gene Therapies
TSHA
$884M
| $23.2K | ﹤0.01% |
+10,063
| New | +$23.2K |
|
1791
Getty Images
GETY
$788M
| $22.7K | ﹤0.01% |
+13,688
| New | +$22.7K |
|
1792
Lineage Cell Therapeutics
LCTX
$283M
| $20.9K | ﹤0.01% |
+23,040
| New | +$20.9K |
|
1793
Outlook Therapeutics
OTLK
$41.2M
| $17.5K | ﹤0.01% |
+10,968
| New | +$17.5K |
|
1794
NextCure
NXTC
$13.2M
| $17.2K | ﹤0.01% |
3,112
| – | – |
|
1795
Geron
GERN
$874M
| $16.5K | ﹤0.01% |
+11,731
| New | +$16.5K |
|
1796
Zura Bio
ZURA
$144M
| $14.5K | ﹤0.01% |
+13,841
| New | +$14.5K |
|
1797
LanzaTech
LNZA
$44.4M
| $14.5K | ﹤0.01% |
536
+369
| +221% | +$10K |
|
1798
Pacific Biosciences
PACB
$375M
| $13.8K | ﹤0.01% |
11,154
-270
| -2% | -$335 |
|
1799
ProKidney
PROK
$298M
| $13.6K | ﹤0.01% |
+23,051
| New | +$13.6K |
|
1800
ProMIS Neurosciences
PMN
$21.8M
| $12.6K | ﹤0.01% |
26,042
| – | – |
|